Request for clarification from Ruiter et al regarding 'Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study'.
B
B
Carstensen
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007328:Insulin / Q000031:analogs & derivatives*; D049528:Insulin, Long-Acting / Q000009:adverse effects*; D061386:Insulin, Regular, Human / Q000009:adverse effects*; D008297:Male; D009369:Neoplasms / Q000139:chemically induced*
D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D061386:Insulin, Regular, Human